Close Menu

NEW YORK (GenomeWeb) – Amgen and Boston Children's Hospital announced yesterday that they have entered into a one-year research collaboration aimed at identifying novel genes underlying anomalies of pain sensitivity, and validating the genetic findings as possible targets for therapeutics.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Los Angeles brought and settled a civil enforcement action against the makers of an at-home test for SARS-CoV-2, NPR reports. 

Technology Review examines factors affecting SARS-CoV-2 testing turnaround times.

In PNAS this week: mapping of ancient human migrations in Europe, recurrent gene fusion in breast cancer, and more.

Retraction Watch writes that a cancer researcher has had an eighth paper retracted.